| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PMV Pharmaceuticals, Inc. | Chief Financial Officer | Common Stock | 60,146 | $64,037 | $1.06 | 01 Jul 2025 | Direct |
| PMV Pharmaceuticals, Inc. | Chief Financial Officer | Employee Stock Option (right to buy) | 265,000 | 03 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PMVP | PMV Pharmaceuticals, Inc. | 01 Jul 2025 | 1 | -$30,077 | 4 | Chief Financial Officer | 03 Jul 2025, 19:49 |
| PMVP | PMV Pharmaceuticals, Inc. | 03 Mar 2025 | 1 | $0 | 4 | Chief Financial Officer | 05 Mar 2025, 18:34 |
| PMVP | PMV Pharmaceuticals, Inc. | 11 Sep 2024 | 1 | -$4,347 | 4 | Chief Financial Officer | 12 Sep 2024, 17:59 |
| PMVP | PMV Pharmaceuticals, Inc. | 13 Aug 2024 | 5 | $0 | 4 | Chief Financial Officer | 03 Oct 2024, 16:48 |
| PMVP | PMV Pharmaceuticals, Inc. | 18 Jan 2024 | 2 | $0 | 4 | Chief Financial Officer | 22 Jan 2024, 16:04 |
| PMVP | PMV Pharmaceuticals, Inc. | 05 Jan 2024 | 0 | $0 | 3 | Chief Financial Officer | 11 Jan 2024, 16:18 |